Daniel Martins

Dr. Daniel Martins

orcid
MD, PhD

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
SMSibila Marques
Sibila Marques
JMJoão Mariano
João Mariano
JMJoana Simão Mendonça
Joana Simão Mendonça
WTWouter De Tavernier
Wouter De Tavernier
MHMoritz Hess
Moritz Hess
DMDaniel Martins
Daniel Martins
Ageism is a widespread phenomenon and constitutes a significant threat to older people’s well-being. Identifying the factors contributing to ageism is critical to inform policies that minimise its societal impact. In this systematic review, we gathered and summarised empirical studies exploring the key determinants of ageism against older people for a period of over forty years (1970–2017). A comprehensive search using fourteen databases identified all published records related to the umbrella concept of “ageism”. Reviewers independently screened the final pool to identify all papers focusing on determinants, according to a predefined list of inclusion and exclusion criteria. All relevant information was extracted and summarised following a narrative synthesis approach. A total of 199 papers were included in this review. We identified a total of 14 determinants as robustly associated with ageism. Of these, 13 have an effect on other-directed ageism, and one on self-directed ageism. The quality of contact with older people and the positive or negative presentation of older people to others emerged as the most robust determinants of other-directed ageism; self-directed ageism is mostly determined by older adults’ health status. Given the correlational nature of most studies included in this review, inferences on causality should be made cautiously.

1 December 2021 in Cell Reports
Verified
Journal Article
Open access
DMDaniel Martins
Daniel Martins
AGAlessio Giacomel
Alessio Giacomel
SWSteven C.R. Williams
Steven C.R. Williams
FTFederico Turkheimer
Federico Turkheimer
ODOttavia Dipasquale
Ottavia Dipasquale
MVMattia Veronese
Mattia Veronese
The integration of transcriptomic and neuroimaging data, "imaging transcriptomics," has recently emerged to generate hypotheses about potential biological pathways underlying regional variability in neuroimaging features. However, the validity of this approach is yet to be examined in depth. Here, we sought to bridge this gap by performing transcriptomic decoding of the regional distribution of well-known molecular markers spanning different elements of the biology of the healthy human brain. Imaging transcriptomics identifies biological and cell pathways that are consistent with the known biology of a wide range of molecular neuroimaging markers. The extent to which it can capture patterns of gene expression that align well with elements of the biology of the neuroinflammatory axis, at least in healthy controls without a proinflammatory challenge, is inconclusive. Imaging transcriptomics might constitute an interesting approach to improve our understanding of the biological pathways underlying regional variability in a wide range of neuroimaging phenotypes.

1 March 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
DMDaniel Martins
Daniel Martins
LRL. Rademacher
L. Rademacher
AGA.S. Gabay
A.S. Gabay
RTR. Taylor
R. Taylor
JRJ.A. Richey
J.A. Richey
YPY. Paloyelis
Y. Paloyelis

11 December 2020 in eLife
Verified
Journal Article
Open access
DMDaniel Martins
Daniel Martins
AGAnthony S Gabay
Anthony S Gabay
MMMitul Mehta
Mitul Mehta
YPYannis Paloyelis
Yannis Paloyelis
Single measurements of salivary and plasmatic oxytocin are used as indicators of the physiology of the oxytocin system. However, questions remain about whether they are sufficiently stable to provide valid trait markers of the physiology of the oxytocin system, and whether salivary oxytocin can accurately index its plasmatic concentrations. Using radioimmunoassay, we measured baseline plasmatic and/or salivary oxytocin from two independent datasets. We also administered exogenous oxytocin intravenously and intranasally in a triple dummy, within-subject, placebo-controlled design and compared baseline levels and the effects of routes of administration. Our findings question the use of single measurements of baseline oxytocin concentrations in saliva and plasma as valid trait markers of the physiology of the oxytocin system in humans. Salivary oxytocin is a weak surrogate for plasmatic oxytocin. The increases in salivary oxytocin observed after intranasal oxytocin most likely reflect unabsorbed peptide and should not be used to predict treatment effects.

1 October 2014 in Neuropharmacology
Verified
Journal Article
Closed access
DMDaniel Martins
Daniel Martins
Isaura TavaresIsaura Tavares
Isaura Tavares
CMC. Morgado
C. Morgado

1 July 2018 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
NTNuno Torres
Nuno Torres
DMDaniel Martins
Daniel Martins
António J. SantosAntónio J. Santos
António J. Santos
DPDiana Maria Pinto Prata
Diana Maria Pinto Prata
MVManuela Veríssimo
Manuela Veríssimo
The hypothalamic nonapeptides oxytocin and vasopressin are important modulators of socio-affective behaviours in a wide variety of animal species, including humans. Nevertheless, there is little research addressing their possible roles on socio-affective dimensions of human behaviour across development, during which considerable behavioural and physiological change occurs. Questions still remain about the extent to which findings from adults may directly apply to earlier phases of human development. In this article, we systematically summarize and discuss all existing studies investigating the developmental association of endogenous levels of hypothalamic neuropeptides oxytocin and vasopressin with human social behaviour or on its disruption in paediatric populations. Evidence is sparse insofar as there are still relatively few developmental studies and limited due to correlational research designs and unreliability of methods currently used for neuropeptide measurements in biological fluids. The findings to date generally converge with adult evidence, but also suggest that important differences between age stages may exist. Further studies focusing these differences may prove critical for informing drug development for socio-affective deficits in paediatric populations.